Diabetic Eye Disease ViewpointCarl Zeiss Case StudiesRetina in 2020

Cataract & RefractiveCorneaGene TherapyGlaucomaInflammation & InfectionPaediatricsRetina

Medical World NewsPodcastsViewpoints

EducationSponsored ResourcesZeiss Case Studies

eNewsletterPrint Subscription

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2021 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.

Spotlight

Diabetic Eye Disease Viewpoint
Carl Zeiss Case Studies
Retina in 2020

ClinicalSee All >

Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2021 MJH Life Sciences^™ and Opthalmology Times Europe. All rights reserved.

Primary treatment: SLT effective first

October 1, 2011

Initial use lowers IOP better than adunctive use, study finds